{
  "state": "hawaii",
  "path": "title-title-25-professions-and-occupations/chapter-461-pharmacists-and-pharmacy",
  "sections": [
    {
      "id": "section-461-1",
      "number": "461-1",
      "heading": "Definitions.461-2 Board of pharmacy; appointment; qualifications",
      "text": "§461-1 Definitions.For the purposes of this chapter:\n\n\"Advanced practice registered nurse\" means a person licensed pursuant to section 457-8.5 and granted prescriptive authority pursuant to section 457-8.6.\n\n\"Board\" means the board of pharmacy of the State except where another meaning is clearly manifested by the context.\n\n\"Caregiver\" means an individual who has an established personal or professional relationship with the individual at risk for an opioid overdose.\n\n\"CLIA-waived tests\" means any test that is classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. 263a).\n\n\"Continuing education courses\" means courses approved by the Accreditation Council for Pharmacy Education.\n\n\"Contraceptive supplies\" means all United States Food and Drug Administration-approved self-administered hormonal contraceptives.\n\n\"Cosmetics\", which includes \"soap\", \"dentifrice\", and \"toilet article\", means:\n\n(1) Articles intended to be rubbed, poured, or sprinkled on, introduced into, or otherwise applied to the human body, or any part thereof, for cleansing, beautifying, or promoting attractiveness; and\n\n(2) Articles intended for use as a component of any such articles.\n\n\"Credit hour\", except as otherwise provided, means the value assigned to sixty minutes of instruction.\n\n\"Director\" means the director of commerce and consumer affairs.\n\n\"Drug\" means:\n\n(1) Articles recognized in the official United States pharmacopoeia, official homeopathic pharmacopoeia of the United States, or official national formulary, or any supplement to any of them;\n\n(2) Articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in human beings or animals;\n\n(3) Articles (other than food or clothing) intended to affect the structure or any function of the body of human beings or animals; and\n\n(4) Articles intended for use as a component of any articles specified in paragraph (1), (2), or (3), above; provided that the term \"drug\" shall not include devices or their components, parts, or accessories, cosmetics, or liquor as defined in section 281-1.\n\n\"Emergency contraception\" means a drug that:\n\n(1) Is used postcoitally;\n\n(2) Prevents pregnancy by delaying ovulation, preventing fertilization of an egg, or preventing implantation of an egg in a uterus; and\n\n(3) Is approved by the United States Food and Drug Administration.\n\n\"Encumbered license\" means a license issued by any state or territory of the United States for the practice of pharmacy which is revoked, suspended, or made probationary or conditional by the licensing or registering authority in the respective jurisdiction as a result of disciplinary action.\n\n\"End-user's external accessible device\" means a commercially available computer, mobile phone, or other communications device that is able to receive electronic information transmitted from an external source and provide the electronic information in a form and format accessible to the individual.\n\n\"Family member\" means an individual who can provide assistance and is related to the individual at risk for an opioid overdose.\n\n\"Institutional facility\" means an organization or facility whose primary purpose is to provide a physical environment for patients to obtain health care services or at-home care services, and that uses the services of an on-site pharmacy, an off-site pharmacy, or a pharmacist contractor at which medication storage is managed by personnel of the facility. \"Institutional facility\" includes but is not limited to a:\n\n(1) Hospital;\n\n(2) Convalescent home;\n\n(3) Skilled nursing facility;\n\n(4) Intermediate care facility;\n\n(5) Extended care facility;\n\n(6) Rehabilitation center;\n\n(7) Health maintenance organization clinic;\n\n(8) Psychiatric center;\n\n(9) Intellectual disability center;\n\n(10) Penal institution;\n\n(11) Hospice facility;\n\n(12) Supervised living group; or\n\n(13) Prescribing practitioner's office.\n\n\"Licensed physician\" means a physician or osteopathic physician licensed by the Hawaii medical board pursuant to chapter 453.\n\n\"Medical oxygen\" means the prescription drug oxygen.\n\n\"Medical oxygen distributor\" means any person, including a prescription drug wholesale distributor, who distributes or dispenses medical oxygen pursuant to a prescription.\n\n\"Pharmacy\" means every store, shop, or place:\n\n(1) Where prescription drugs are dispensed or sold at retail, or displayed for sale at retail;\n\n(2) Where practitioners' prescriptions or drug preparations are compounded;\n\n(3) That has upon it, displayed within it, or affixed to or used in connection with it, a sign bearing the words \"pharmacist\", \"pharmacy\", \"apothecary\", \"drug store\", \"druggist\", \"drugs\", \"medicines\", \"medicine store\", \"drug sundries\", \"remedies\", or any words of similar or like import; or\n\n(4) Where any of the above words or combination of words are used in any advertisement.\n\nThe term \"pharmacy\" shall not include any medical oxygen distributor.\n\n\"Practice of pharmacy\" means:\n\n(1) The interpretation and evaluation of prescription orders; the compounding, dispensing, and labeling of drugs and devices (except labeling by a manufacturer, packer, or distributor of nonprescription drugs and commercially legend drugs and devices); the participation in drug selection and drug utilization reviews; the proper and safe storage of drugs and devices and the maintenance of proper records therefor; the responsibility for advising when necessary or where regulated, of therapeutic values, content, hazards, and use of drugs and devices; and the interpretation and evaluation of prescription orders to adjust the supply dispensed for purposes of medication synchronization pursuant to section 431:10A-606, 432:1-621, or 432D-30;\n\n(2) Performing the following procedures or functions as part of the care provided by and in concurrence with a \"health care facility\" and \"health care service\" as defined in section 323D-2; or a \"pharmacy\"; or a licensed physician, a licensed physician assistant, ora licensed advanced practice registered nurse with prescriptive authority; or a \"managed care plan\" as defined in section 432E-1, in accordance with policies, procedures, or protocols developed collaboratively by health professionals, including physicians and surgeons, pharmacists, physician assistants, and registered nurses, and for which a pharmacist has received appropriate training required by these policies, procedures, or protocols:\n\n(A) Ordering or performing routine drug therapy related patient assessment procedures;\n\n(B) Ordering drug therapy related laboratory tests;\n\n(C) Initiating emergency contraception oral drug therapy in accordance with a written collaborative agreement approved by the board, between a licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority and a pharmacist who has received appropriate training that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE), curriculum-based programs from an ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board;\n\n(D) Administering drugs orally, topically, by intranasal delivery, or by injection, pursuant to the order of the patient's licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority, by a pharmacist having appropriate training that includes programs approved by the ACPE, curriculum-based programs from an ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board;\n\n(E) Administering:\n\n(i) Immunizations orally, by injection, or by intranasal delivery, to persons eighteen years of age or older by a pharmacist having appropriate training that includes programs approved by the ACPE, curriculum-based programs from an ACPE-accredited college of pharmacy, state or local health department programs, or programs recognized by the board;\n\n(ii) Vaccines to persons between fourteen and seventeen years of age pursuant to section 461-11.4; and\n\n(iii) Human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines to persons between eleven and seventeen years of age pursuant to section 461-11.4;\n\n(F) As authorized by the written instructions of a licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority, initiating or adjusting the drug regimen of a patient pursuant to an order or authorization made by the patient's licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority and related to the condition for which the patient has been seen by the licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority; provided that the pharmacist shall issue written notification to the patient's licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority or enter the appropriate information in an electronic patient record system shared by the licensed physician, physician assistant, or advanced practice registered nurse with prescriptive authority, within twenty-four hours;\n\n(G) Transmitting a valid prescription to another pharmacist for the purpose of filling or dispensing;\n\n(H) Providing consultation, information, or education to patients and health care professionals based on the pharmacist's training and for which no other licensure is required; or\n\n(I) Prescribing and dispensing an opioid antagonist pursuant to section 461-11.8;\n\n(3) The offering or performing of those acts, services, operations, or transactions necessary in the conduct, operation, management, and control of pharmacy;\n\n(4) Prescribing and dispensing contraceptive supplies pursuant to section 461-11.6; and\n\n(5) Notwithstanding any other law to the contrary, and in accordance with the requirements of section 461-11.2, ordering, performing, and reporting the results of the following CLIA-waived tests:\n\n(A) Blood glucose;\n\n(B) Hemoglobin A1C;\n\n(C) Hepatitis C;\n\n(D) Human immunodeficiency virus;\n\n(E) Influenza;\n\n(F) Respiratory syncytial virus;\n\n(G) SARS-CoV-2; or\n\n(H) Streptococcal pharyngitis.\n\n\"Practitioner\" means an individual licensed by the State or authorized by the laws of the State to prescribe prescription drugs within the scope of the person's practice.\n\n\"Prescription\" means an order or formula issued by a practitioner licensed by the State or authorized by the laws of the State to prescribe prescription drugs within the scope of the practitioner's practice, for the compounding or dispensing of drugs or an order or formula issued by an out-of-state practitioner in compliance with chapter 328.\n\n\"Prescription drug\" means any drug dispensed, distributed, or sold pursuant to a practitioner's order.\n\n\"Prescription drug reader\" means a dedicated electronic device that is able to obtain information from an electronic label affixed to a container of prescription drugs and provide the information in an audio format accessible to the individual.\n\n\"Registered pharmacist\" means a person licensed under this chapter to practice in a pharmacy except where another meaning is clearly manifested by the context.\n\n\"Remote dispensing machine\" means a device used for dispensing unit-of-use drugs that is operated using information technologies and is located in a remote dispensing pharmacy.\n\n\"Remote dispensing pharmacy\" means the area in an institutional facility, including a federally qualified health center that provides outpatient medical care in any county, where prescription drugs are dispensed through the use of a remote dispensing machine.\n\n\"Territory\" means Puerto Rico, the Northern Mariana Islands, the Virgin Islands, Guam, or American Samoa.\n\n\"Unit of use container\" means one that contains a specific quantity of a drug product and that is intended to be dispensed as such without further modification except for the addition of appropriate labeling. A unit of use container is labeled as such. [L 1949, c 175, pt of §1; RL 1955, §71-1; am L 1964, c 15, §4; HRS §461-1; am L 1986, c 143, §4; am L 1987, c 188, §1; am L 1995, c 34, §1; am L 1996, c 202, §11; am L 1997, c 214, §8; am L 2000, c 83, §6; am L 2002, c 256, §2; am L 2003, c 201, §2; am L 2004, c 165, §2, c 190, § §6, 11 and c 239, §1; am L 2008, c 9, §3 and c 212, § §3, 7; am L 2009, c 11, §62 and c 96, §3; am L 2010, c 50, §2 and c 51, §2; am L 2011, c 220, §12; am L 2012, c 24, §2 and c 42, §3; am L 2013, c 184, §2; am L 2015, c 36, §1; am L 2016, c 68, §3 and c 183, §9; am L 2017, c 67, §5 and c 68, §2; am L 2018, c 154 §3 and c 197, §5; am L 2022, c 293, §12; am L 2023, c 103, §3 and c 256, §3]\n\nThe L 2012, c 24, §2 amendment applies to license renewals for the licensing biennium beginning January 1, 2014. L 2012, c 24, §4.\n\nThe L 2010, c 51 amendment is exempt from the January 2, 2014 repeal and reenactment condition of L 2009, c 96, §3. L 2010, c 51, §5.\n\nLaw Journals and Reviews\n\nEmergency Contraception in Religious Hospitals: The Struggle Between Religious Freedom and Personal Autonomy. 27 UH L. Rev. 65 (2004).\n\nCompelled Expression of the Religiously Forbidden: Pharmacists, \"Duty to Fill\" Statutes, and the Hybrid Rights Exception. 29 UH L. Rev. 97 (2006).",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-1/"
    },
    {
      "id": "section-461-2",
      "number": "461-2",
      "heading": "Board of pharmacy; appointment; qualifications.",
      "text": "§461-2 Board of pharmacy; appointment; qualifications.There shall be a board of pharmacy of seven members.\n\nFive members of the board shall be graduates of a school or college of pharmacy and shall have been licensed as pharmacists and actively engaged in the practice of pharmacy for at least five years prior to their appointment and two shall be public members. Four members of the board shall be residents of the city and county of Honolulu and three shall be residents of counties other than the city and county of Honolulu. [L 1949, c 175, pt of §1; RL 1955, §71-2; am L Sp 1959 2d, c 1, § §5, 15; HRS §461-2; am L 1978, c 208, §11; am L 1992, c 202, §135; am L 1993, c 322, §12]\n\nCross References\n\nDepartmental administration, see § §26-9 and 26-35.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-2/"
    },
    {
      "id": "section-461-3",
      "number": "461-3",
      "heading": "Records.",
      "text": "§461-3 Records.The executive secretary, subject to the direction of the board, shall make and keep all records and record books required to be kept by the board and shall furnish the department of health with copies of those records as it requires. [L 1949, c 175, pt of §1; RL 1955, §71-3; am L 1957, c 152, §1; am L Sp 1959 2d, c 1, § §14, 15, 19; am L 1961, c 184, §15; am L 1963, c 114, § §1, 3; HRS §461-3; am L 1983, c 23, §1; gen ch 1985; am L 1986, c 143, §5; am L 1992, c 202, §136]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-3/"
    },
    {
      "id": "section-461-4",
      "number": "461-4",
      "heading": "REPEALED.",
      "text": "§461-4 REPEALED.\n\nL 1992, c 202, §225.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-4/"
    },
    {
      "id": "section-461-45",
      "number": "461-4.5",
      "heading": "Powers and duties.",
      "text": "§461-4.5 Powers and duties.(a) In addition to any other powers and duties authorized by law, the board:\n\n(1) Shall adopt, amend, and repeal rules pursuant to chapter 91, as it deems proper for the purposes of this chapter, Public Law 100-293, and title 21 Code of Federal Regulations part 205;\n\n(2) Shall examine, license, reinstate, and renew the licenses of qualified applicants for registered pharmacists and wholesale prescription drug distributors, and issue and renew permits to operate pharmacies;\n\n(3) May require the inspection of any wholesale prescription drug distributor premises in the State to ensure compliance with this chapter and rules adopted under this chapter, or may require an applicant for a pharmacy license to submit a statement that the premises, including but not limited to security and sanitation, are in conformance with the board's requirements and that the applicant possesses the reference materials and technical clinical equipment and supplies as may be specified in rules adopted under this chapter;\n\n(4) May fine, suspend, or revoke any license or permit for any cause prescribed by this chapter, or for any violation of the rules adopted under this chapter, and refuse to grant or renew any license or permit for any cause which would be ground for revocation or suspension of a license or permit;\n\n(5) May deny a license to any applicant who has been disciplined by another state or federal agency. Notwithstanding any law to the contrary, a final order of disciplinary action taken pursuant to this paragraph shall be a matter of public record; and\n\n(6) May approve pilot and demonstration research projects for innovative applications in the practice of pharmacy; provided that the projects shall not include therapeutic substitution or substitution of a medical device used in patient care; provided further that nothing in this paragraph shall be construed to expand the definition of \"practice of pharmacy\" as defined under section 461-1. The board may also:\n\n(A) Approve a provision that grants an exception to any rule adopted under this paragraph;\n\n(B) Extend the time an exception to a rule is granted, as may be necessary for the board to adopt an amendment or modification to the rule;\n\n(C) Condition approval of a project upon compliance with this section and any rules adopted under this section; and\n\n(D) Rescind approval and terminate a project if, at any time, a project fails to protect public health or welfare.\n\n(b) Nothing in this chapter shall modify or limit any powers of the board or the department of health of this State. [L 1986, c 143, §1; am L 1992, c 196, §4 and c 202, §137; am L 1997, c 38, §4; am L 2016, c 38, §9; am L 2019, c 222, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-4-5/"
    },
    {
      "id": "section-461-5",
      "number": "461-5",
      "heading": "Qualifications for license.",
      "text": "§461-5 Qualifications for license.(a) Any applicant for a license as a pharmacist shall submit an application on a form prescribed by the board and shall provide evidence to the board that the applicant:\n\n(1) Is at least eighteen years of age;\n\n(2) Holds a degree from a school or college of pharmacy or department in a university which is recognized and accredited by the American Council of Pharmaceutical Education;\n\n(3) Has a minimum of fifteen hundred hours of practical experience in any state or territory of the United States, or the District of Columbia, under the supervision of a pharmacist who is duly registered or licensed in the state, territory, or district where the experience is obtained. Service and experience under the supervision of a registered pharmacist as required in this section shall be predominantly related to the practice of pharmacy as defined under section 461-1. In the event an applicant has no practical experience as required, the applicant may take the examination and upon passing the examination, shall not receive a license until after the applicant fulfills the practical experience requirement;\n\n(4) Has passed an examination as may be prescribed by the board; and\n\n(5) Does not have an encumbered license or a pending disciplinary action or unresolved complaint in the practice of pharmacy in any state or territory of the United States, or the District of Columbia, or if any license has been or is encumbered, the applicant shall provide all information requested by the board.\n\n(b) Any applicant who is otherwise qualified to apply for a license to practice pharmacy in this State, but who is a graduate of a school or college of pharmacy located outside the United States which has not been recognized by the board as an accredited school, may be deemed to have satisfied the requirement of subsection (a)(2) by providing verification to the board of the applicant's academic record and graduation and by meeting other requirements as the board may establish from time to time. The board shall require the applicant to successfully pass an examination or examinations given or approved by the board to establish proficiency in English if the school is located outside the United States in a country where the official language is not English, and equivalency of education of the applicant with qualified graduates of a school or college recognized by the board as a prerequisite to taking the licensure examination required by section 461-6. [L 1949, c 175, pt of §1; RL 1955, §71-5; HRS §461-5; am L 1971, c 131, §1; am L 1972, c 2, §25; am L 1973, c 105, §1; am L 1985, c 223, §1; am L 1990, c 248, §1; am L 1992, c 202, §138; am L 1994, c 39, §2; am L 1995, c 34, §2; am L 2010, c 50, §3]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-5/"
    },
    {
      "id": "section-461-6",
      "number": "461-6",
      "heading": "Examination; license.",
      "text": "§461-6 Examination; license.(a) Every applicant for a license as a pharmacist shall meet all qualifications set by the board including, but not limited to, passing all examinations as prescribed by rules of the board. The board shall determine the passing score for each examination.\n\n(b) Every applicant for a license as a pharmacist, except an applicant applying under section 461-8.5, shall apply on a form to be supplied by the board and shall either file the form with the board at least sixty days before the examination, or if taking the examination in another state pursuant to the National Association of Boards of Pharmacy Score Transfer Program, shall file the form no later than ninety days after the examination. Each application shall be accompanied by application and examination fees. The board shall establish the schedule for examinations.\n\n(c) Each applicant who successfully passes each required examination and meets all other requirements of the board shall pay a license fee.\n\n(d) An applicant who fails an examination shall file an application for reexamination in the examination for which a passing score was not achieved and shall not be licensed until the applicant successfully passes all of the licensure examinations. [L 1949, c 175, pt of §1; RL 1955, §71-6; am L 1957, c 316, §11; HRS §461-6; am L 1979, c 10, §1; am L 1984, c 7, §62; am L 1986, c 143, §7; am L 1988, c 74, §1; am L 1992, c 196, §5; am L 1995, c 34, §3; am L 1998, c 42, §1]\n\nCross References\n\nDisposal of examination records, see §94-5.\n\nProfessional testing services, see §26-9.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-6/"
    },
    {
      "id": "section-461-7",
      "number": "461-7",
      "heading": "Temporary license.",
      "text": "§461-7 Temporary license.(a) A registered pharmacist of any state or territory of the United States who does not have an encumbered license or any pending disciplinary action or unresolved complaints in any state or territory of the United States and who is not eligible for licensure by reciprocity under section 461-8.5 may be granted a temporary license by the board; provided that the person shall first pass a jurisprudence examination as required by the board.\n\n(b) A temporary license shall not entitle the holder to a permanent license, and no permanent license shall be issued until the person has passed the remaining licensure examinations set forth in section 461-6. Only one temporary license shall be issued to the same applicant.\n\n(c) A temporary license shall only remain in effect until the results of the next licensure examinations are announced; provided that the board may extend any temporary license, upon written request, and for good and just cause. Any applicant who fails to take or to pass the next licensure examination shall surrender the temporary license. The board shall receive a fee for the issuance of a temporary license. [L 1949, c 175, pt of §1; RL 1955, §71-7; am L 1961, c 142, §8(a); HRS §461-7; am L 1972, c 62, §1; am L 1973, c 105, §2; am L 1984, c 7, §63; am L 1985, c 223, §2; am L 1986, c 143, §8; am L 1988, c 74, §2; am L 1990, c 248, §2; am L 1995, c 34, §4; am L 1998, c 42, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-7/"
    },
    {
      "id": "section-461-8",
      "number": "461-8",
      "heading": "Renewal of licenses; continuing education requirement.",
      "text": "§461-8 Renewal of licenses; continuing education requirement.(a) All licenses issued by the board, except temporary licenses issued under section 461-7, shall be renewed biennially on or before December 31 of each odd-numbered year. Failure to pay the biennial fee and, beginning with the renewal for the licensing biennium commencing on January 1, 2008, to satisfy the continuing education requirement on or before December 31 of each odd-numbered year, shall constitute a forfeiture of the license as of the date of expiration.\n\n(b) Any license forfeited pursuant to subsection (a) may be restored within three years upon payment of any penalty fee, the current biennial fees, and the renewal fee for the next biennium, if applicable, upon submission of proof of compliance with the continuing education requirement for the prior biennium, and upon meeting any other requirements specified in rules adopted pursuant to chapter 91.\n\n(c) In the event that the pharmacist has not engaged in the practice of pharmacy in this State or in another state or territory of the United States within the past five years, the board may require the pharmacist to satisfy additional requirements, as specified in rules adopted pursuant to chapter 91, to demonstrate that the pharmacist is competent to practice in this State.\n\n(d) Beginning with the renewal for the licensing biennium commencing on January 1, 2008, and every biennial renewal thereafter, each licensee shall have completed thirty credit hours in continuing education courses within the two-year period preceding the renewal date, regardless of the licensee's initial date of licensure; provided that a licensee who has graduated from an accredited pharmacy school within one year of the licensee's first license renewal period shall not be subject to the continuing education requirement for the first license renewal. The board may extend the deadline for compliance with the continuing education requirement based on any of the following:\n\n(1) Illness, as certified by a physician or osteopathic physician licensed under chapter 453 or licensed in the jurisdiction in which the licensee was treated;\n\n(2) Military service under extended active duty with the armed forces of the United States;\n\n(3) Lack of access to continuing education courses due to the practice of pharmacy in geographically isolated areas; and\n\n(4) Inability to undertake continuing education due to incapacity, undue hardship, or other extenuating circumstances.\n\n(e) A pharmacist who administers any vaccine to persons between the ages of fourteen and seventeen years or administers the human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, or influenza vaccine to persons between eleven and seventeen years of age pursuant to section 461-11.4 shall complete a training program approved by the board within every other biennial renewal period and submit proof of successful completion of the training program to the board; provided that the pharmacist shall meet these requirements prior to administering any vaccine to persons between the ages of fourteen and seventeen years or administering the human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, or influenza vaccine to persons between eleven and seventeen years of age.\n\n(f) A pharmacist who prescribes and dispenses contraceptive supplies pursuant to section 461-11.6 shall complete an Accreditation Council for Pharmacy Education program approved by the board within every other biennial renewal period and submit proof of successful completion of the continuing education program to the board.\n\n(g) Each licensee shall maintain the licensee's continuing education records. At the time of renewal, each licensee shall certify under oath that the licensee has complied with the continuing education requirement of this section. The board may require a licensee to submit, in addition to the certification, evidence satisfactory to the board that demonstrates compliance with the continuing education requirement of this section.\n\n(h) The board may conduct random audits to determine compliance with the continuing education requirement. The board shall provide written notice of an audit to a licensee randomly selected for audit. Within sixty days of notification, the licensee shall provide the board with documentation verifying compliance with the continuing education requirement. [L 1949, c 175, pt of §1; RL 1955, §71-8; am L 1957, c 316, §12; am L 1961, c 142, §8(b); HRS §461-8; am L 1975, c 118, §25(1); am L 1984, c 7, § §64, 65; am L 1986, c 143, §9; am L 1990, c 248, §3; am L 1996, c 208, §3; am L 2004, c 165, §3; am L 2009, c 11, §63; am L 2012, c 42, §4; am L 2015, c 36, §2; am L 2017, c 67, §6 and c 68, §3]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-8/"
    },
    {
      "id": "section-461-85",
      "number": "461-8.5",
      "heading": "Reciprocity.",
      "text": "§461-8.5 Reciprocity.(a) Any pharmacist who is registered or licensed under the laws of any state or territory of the United States with qualifications for licensure which equal or exceed those of this State, shall be eligible for licensure; provided that:\n\n(1) The pharmacist possesses a current valid license;\n\n(2) The pharmacist has practiced as a registered pharmacist for fifteen hundred hours or more within the five years preceding the date of application;\n\n(3) There is no disciplinary action pending or other unresolved complaints against the pharmacist in any state or territory of the United States;\n\n(4) The pharmacist does not have an encumbered license or a pending disciplinary action or unresolved complaint in the practice of pharmacy in any state or territory of the United States, or if any license has been or is encumbered, the pharmacist shall provide any information requested by the board; and\n\n(5) The laws of the other state or territory grant reciprocal treatment to licensees of this State.\n\nThe board may examine these licensees only as to knowledge of this State's statutes and rules.\n\n(b) An applicant applying for licensure pursuant to this section shall provide proof that the standards upon which licensure was granted by another state or territory of the United States are at least equivalent to the licensing standards that were in effect in this State under sections 461-5 and 461-6 at the time licensure in the other state or territory was granted.\n\n(c) An applicant for reciprocity who is unable to demonstrate that licensure was based on standards at least equal to those in sections 461-5 and 461-6, may be issued a temporary license while fulfilling requirements necessary for licensure in this State. The requirements and limitations of a temporary license shall be the same as those under section 461-7. [L 1985, c 264, §2; am L 1990, c 248, §4; am L 1994, c 39, §3; am L 1995, c 34, §5; am L 1996, c 208, §4]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-8-5/"
    },
    {
      "id": "section-461-86",
      "number": "461-8.6",
      "heading": "Wholesale prescription drug distributor license.",
      "text": "§461-8.6 Wholesale prescription drug distributor license.It shall be unlawful for any person to operate, maintain, open, change location, or establish any wholesale prescription drug distribution business within the State without first having obtained a license from the board. [L 1992, c 196, §3]\n\nCross References\n\nRegulation of wholesale prescription drug distributors, see chapter 328, pt VII.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-8-6/"
    },
    {
      "id": "section-461-9",
      "number": "461-9",
      "heading": "Pharmacist in charge; pharmacy personnel.",
      "text": "§461-9 Pharmacist in charge; pharmacy personnel.(a) A registered pharmacist shall be in personal and immediate charge of the pharmacy and personnel employed in the pharmacy. Temporary absences of the registered pharmacist shall be unlawful except for periods of time and under circumstances as authorized under the rules of the board. During any absence of the registered pharmacist, prescriptions may not be filled, compounded, or received by telephone and no drugs shall be sold; provided that this shall not preclude the sale at those times of things that might be sold were the pharmacy a store not subject to this chapter. No person other than a registered pharmacist or a pharmacy intern under the registered pharmacist's immediate supervision shall fill or compound prescriptions except as provided by subsection (c).\n\n(b) No person shall practice as a pharmacy intern without having first obtained a permit from the board. The board shall adopt rules pursuant to chapter 91 defining the functions of a pharmacy intern, establishing the requirements to be met by an applicant for a pharmacy intern permit, and specifying the duration of the permit and the procedures for the immediate supervision of the pharmacy intern by a registered pharmacist.\n\n(c) A pharmacy technician may be employed to assist the registered pharmacist under rules adopted by the board pursuant to chapter 91 that define the qualifications and functions of the pharmacy technician and provide the procedures for control and supervision by a registered pharmacist. [L 1949, c 175, pt of §1; RL 1955, §71-9; HRS §461-9; am L 1983, c 23, §3; am L 1985, c 223, §3; gen ch 1985; am L 1986, c 143, §10; am L 1993, c 112, §1]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-9/"
    },
    {
      "id": "section-461-10",
      "number": "461-10",
      "heading": "Pharmacies.",
      "text": "§461-10 Pharmacies.Any proprietor or manager of a pharmacy who fails or neglects to place a registered pharmacist in charge thereof or who permits the compounding of prescriptions, or the vending of drugs, except by or under the immediate supervision of a registered pharmacist, shall be deemed to have violated this chapter. Any person who, not being a registered pharmacist, compounds prescriptions or vends drugs, while not subject to the immediate supervision of a registered pharmacist, shall be deemed to have violated this chapter. [L 1949, c 175, pt of §1; RL 1955, §71-10; HRS §461-10]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-10/"
    },
    {
      "id": "section-461-102",
      "number": "461-10.2",
      "heading": "Return for disposal of unused, remaining, or expired drugs; pharmacy options.",
      "text": "§461-10.2 Return for disposal of unused, remaining, or expired drugs; pharmacy options.(a) No pharmacy shall accept the return of any prescription drug unless:\n\n(1) The pharmacy is collecting the prescription drug for disposal only; and\n\n(2) The pharmacy is registered with the United States Drug Enforcement Administration as an authorized collector pursuant to title 21 Code of Federal Regulations section 1317.40.\n\n(b) No prescription drug returned to the pharmacy for disposal shall be redispensed or returned for cash or credit.\n\n(c) Any pharmacy accepting prescription drugs for disposal shall use the following methods:\n\n(1) Secured collection receptacles in compliance with title 21 Code of Federal Regulations section 1317.75; or\n\n(2) Mail-back programs.\n\n(d) In any pharmacy accepting prescription drugs for disposal under this section, the pharmacist-in-charge shall ensure that only Drug Enforcement Administration approved reverse distributors acquire prescription drugs collected through collection receptacles and mail-back programs. [L 2019, c 183, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-10-2/"
    },
    {
      "id": "section-461-105",
      "number": "461-10.5",
      "heading": "REPEALED.",
      "text": "§461-10.5 REPEALED.\n\nL 2013, c 184, §2.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-10-5/"
    },
    {
      "id": "section-461-11",
      "number": "461-11",
      "heading": "Duties of registered pharmacist.",
      "text": "§461-11 Duties of registered pharmacist.Every registered pharmacist in charge of a pharmacy shall comply with all laws and rules. The pharmacist shall be responsible for the management of the pharmacy and every activity thereof which is subject to this chapter shall be under the pharmacist's complete control.\n\nAll registered pharmacists shall notify the board of changes of business address within ten days. [L 1949, c 175, pt of §1; RL 1955, §71-11; HRS §461-11; am L 1983, c 23, §4; gen ch 1985; am L 1986, c 143, §11; am L 2000, c 11, §1; am L 2001, c 207, §3]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-11/"
    },
    {
      "id": "section-461-112",
      "number": "461-11.2",
      "heading": "CLIA-waived tests; authority; permitting and education requirements; reporting.",
      "text": "§461-11.2 CLIA-waived tests; authority; permitting and education requirements; reporting.(a) Unless otherwise authorized by law, a pharmacist shall only exercise the authority granted under paragraph (5) of the definition of \"practice of pharmacy\" in section 461-1 to order, perform, and report the results of certain CLIA-waived tests:\n\n(1) After completing appropriate training that includes programs approved by the Accreditation Council for Pharmacy Education, curriculum-based programs from an Accreditation Council for Pharmacy Education-accredited college of pharmacy, state or local health department programs, or programs recognized by the board, and any regulations promulgated by the federal Centers for Medicare and Medicaid Services; and\n\n(2) Upon application for and receipt of a permit pursuant to the requirements of section 321-13.\n\n(b) Any pharmacist performing a CLIA-waived test for a patient shall report the results of the test to a minor patient's pediatrician or an adult patient's primary care provider, if such information is provided by the patient at the time of testing. The pharmacist shall attempt to solicit pediatrician or primary care provider information at the time of performing the CLIA-waived test.\n\n(c) For any CLIA-waived tests performed, pharmacists shall follow all applicable state laws and rules regarding the reporting of diseases. [L 2023, c 103, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-11-2/"
    },
    {
      "id": "section-461-114",
      "number": "461-11.4",
      "heading": "Vaccinations; children",
      "text": "§461-11.4 Vaccinations; children. (a) A pharmacist may administer:\n\n(1) A vaccine to persons between fourteen and seventeen years of age pursuant to a valid prescription; and\n\n(2) A human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, or influenza vaccine to persons between eleven and seventeen years of age pursuant to a valid prescription.\n\nThe pharmacist shall verify that the prescriber or the prescriber's authorized agent is the patient's medical home.\n\n(b) After the vaccination is administered, the pharmacist shall immediately provide to the patient a vaccination record including the following information:\n\n(1) The patient's name and date of birth;\n\n(2) The type of vaccine administered; and\n\n(3) The date and location that the vaccine was administered.\n\n(c) The pharmacist shall provide within seventy-two hours to the medical home and within five business days to the department of health immunization registry the same information provided to the patient pursuant to subsection (b) as well as the following:\n\n(1) The name of the vaccine product that was administered, including the manufacturer, lot number, and expiration date;\n\n(2) The method of administration; and\n\n(3) The anatomical site of administration.\n\n(d) All pharmacists who administer vaccines to persons between the ages of fourteen and seventeen years or administer human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, and influenza vaccines to persons between the ages of eleven and seventeen years shall complete a training program approved by the Accreditation Council of Pharmacy Education for which a certificate of completion is issued. The pharmacist shall complete the training program and submit the completion certificate for the training program to the board prior to administering any vaccine to persons between the ages of fourteen and seventeen years and prior to administering any human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, or influenza vaccine to persons between the ages of eleven and seventeen years.\n\n(e) For the purposes of this section, \"medical home\" means the primary care physician who, working in collaboration with the family, oversees the acute, chronic, and preventive health needs of the patient in a comprehensive, coordinated, and continuous fashion. [L 2012, c 42, §2; am L 2015, c 36, §3; am L 2017, c 68, §4]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-11-4/"
    },
    {
      "id": "section-461-115",
      "number": "461-11.5",
      "heading": "REPEALED.",
      "text": "§461-11.5 REPEALED.\n\nL 2004, c 190, § §5, 11; am L 2010, c 51, §3.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-11-5/"
    },
    {
      "id": "section-461-116",
      "number": "461-11.6",
      "heading": "Contraceptive supplies; authority to prescribe and dispense; requirements.",
      "text": "§461-11.6 Contraceptive supplies; authority to prescribe and dispense; requirements.(a) A pharmacist may prescribe and dispense contraceptive supplies to a patient regardless of whether the patient has evidence of a previous prescription for contraceptive supplies from a licensed physician, advanced practice registered nurse, or other primary care provider authorized to prescribe contraceptive supplies.\n\n(b) A pharmacist who prescribes and dispenses contraceptive supplies pursuant to subsection (a) shall:\n\n(1) Complete an Accreditation Council for Pharmacy Education program approved by the board related to prescribing contraceptive supplies;\n\n(2) Provide a self-screening risk assessment tool that a patient shall complete before the pharmacist prescribes any contraceptive supplies; provided that the self-screening risk assessment tool shall be based on the current version of the United States Medical Eligibility Criteria for Contraceptive Use developed by the federal Centers for Disease Control and Prevention;\n\n(3) Refer the patient to the patient's primary care provider upon prescribing and dispensing the contraceptive supplies; provided that if the patient does not have a primary care provider, the pharmacist shall advise the patient to consult a licensed physician, advanced practice registered nurse, or other primary care provider of the patient's choice;\n\n(4) Provide the patient with a written record of the contraceptive supplies prescribed and dispensed and advise the patient to consult with a primary care provider of the patient's choice; and\n\n(5) Dispense the contraceptive supplies to the patient as soon as practicable after the pharmacist issues the prescription.\n\n(c) A pharmacist who prescribes and dispenses contraceptive supplies pursuant to subsection (a) shall not require a patient to schedule an appointment with the pharmacist for the prescribing or dispensing of contraceptive supplies. [L 2017, c 67, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-11-6/"
    },
    {
      "id": "section-461-118",
      "number": "461-11.8",
      "heading": "Opioid antagonist; authority to prescribe and dispense; requirements.",
      "text": "§461-11.8 Opioid antagonist; authority to prescribe and dispense; requirements.[Repeal and reenactment on June 30, 2024. L 2019, c 255,§4.](a) A pharmacist, acting in good faith and exercising reasonable care, may prescribe and dispense an opioid antagonist to an individual who is at risk for an opioid overdose or a family member or caregiver of an individual who is at risk of an opioid overdose regardless of whether the individual has evidence of a previous prescription for an opioid antagonist from a practitioner authorized to prescribe opioids. The opioid antagonist prescribed and dispensed for a family member or caregiver of an individual who is at risk for an opioid overdose may be prescribed and dispensed in the name of the individual who is to be treated with the opioid antagonist or in the name of the individual who is requesting the opioid antagonist, or an \"Opioid Antagonist Recipient\" or \"OAR\".\n\n(b) A pharmacist who prescribes and dispenses opioid antagonists pursuant to subsection (a) shall:\n\n(1) Complete a training program related to prescribing opioid antagonists that is approved by the Accreditation Council for Pharmacy Education (ACPE), a curriculum-based program from an ACPE-accredited college of pharmacy, a state or local health department program, or a program recognized by the board;\n\n(2) Provide the individual who is receiving the opioid antagonist with information and written educational material on risk factors of opioid overdose, signs of an overdose, overdose response steps, and the use of the opioid antagonist; and\n\n(3) Dispense the opioid antagonist to the individual who is at risk for an opioid overdose, family member, caregiver, or individual requesting the opioid antagonist for an individual at risk for an opioid overdose as soon as practicable after the pharmacist issues the prescription. [L 2018, c 154, §2; am L 2019, c 255, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-11-8/"
    },
    {
      "id": "section-461-12",
      "number": "461-12",
      "heading": "Adequate equipment.",
      "text": "§461-12 Adequate equipment.A pharmacy that compounds drugs shall be equipped with adequate pharmaceutical equipment to ensure the proper compounding of prescriptions. The board shall by rules prescribe the minimum of professional and technical equipment and reference materials that a pharmacy shall at all times possess. [L 1949, c 175, pt of §1; RL 1955, §71-12; HRS §461-12; am L 1986, c 143, §12; am L 1998, c 70, §1]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-12/"
    },
    {
      "id": "section-461-13",
      "number": "461-13",
      "heading": "Prescription record.",
      "text": "§461-13 Prescription record.A pharmacy shall keep prescription records of each prescription compounded or dispensed at the pharmacy for a period of not less than five years. The prescription records shall at all times be open to inspection by the board of pharmacy and other law enforcement officers. [L 1949, c 175, pt of §1; RL 1955, §71-13; HRS §461-13; am L 1998, c 70, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-13/"
    },
    {
      "id": "section-461-135",
      "number": "461-13.5",
      "heading": "Pharmacies; prescription drug label information; accessibility.",
      "text": "§461-13.5 Pharmacies; prescription drug label information; accessibility.(a) When dispensing a prescription drug to an individual who, as acknowledged by the individual, has difficulty seeing or reading standard printed labels on prescription drug containers, the dispensing pharmacy shall provide the individual with a means of access to obtain the prescription drug label information required pursuant to section 328-16(a) by:\n\n(1) Including an electronic label affixed to the prescription drug container that transmits prescription drug label information, directions, and written instructions to an end-user's external accessible device, including an individual's compatible prescription drug reader; or\n\n(2) Providing a prescription drug reader at no cost to the individual.\n\n(b) Dispensing pharmacies shall make sustained, periodic, and reasonable efforts to inform the public that prescription drug label information is available in accessible formats for individuals who have difficulty seeing or reading standard printed labels on prescription drug containers.\n\n(c) Dispensing pharmacies shall otherwise follow the best practices as recommended by the United States Access Board for pharmacies in providing independent access to prescription drug label information.\n\n(d) This section shall not apply to a pharmacy that is a sole proprietorship with no more than two pharmacists; provided that the pharmacy has requested and been granted an exemption from the requirements of this section by the board; provided further that the exemption shall be subject to an annual review and approval that the board may grant on a case-by-case basis upon a finding that compliance with this section would result in an undue burden for the pharmacy, determined by the board in accordance with the Americans with Disabilities Act (42 U.S.C. 12182). [L 2023, c 256, §2]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-13-5/"
    },
    {
      "id": "section-461-14",
      "number": "461-14",
      "heading": "Permits for operation of pharmacy.",
      "text": "§461-14 Permits for operation of pharmacy.(a) It shall be unlawful for any person to operate, maintain, open, change location, or establish any pharmacy within the State without first having obtained a permit from the board.\n\n(b) Application for permits shall be made on a form to be prescribed by the board. Separate application shall be made and separate permits issued for each separate place at which is carried on any of the operations for which a permit is required.\n\n(c) On evidence satisfactory to the board, a permit shall be issued, provided:\n\n(1) That the pharmacy for which the permit is sought is or will be, in full compliance with this chapter and rules of the board;\n\n(2) That the location and appointments of the pharmacy are such that it can be operated and maintained without endangering the public health or safety; and\n\n(3) That the pharmacy will be under the personal and immediate supervision of a registered pharmacist.\n\n(d) No application for a permit shall be refused except pursuant to this section and only after notice to the applicant and a full and fair hearing. [L 1949, c 175, pt of §1; RL 1955, §71-14; HRS §461-14; am L 1983, c 23, §5; am L 1986, c 143, §13; am L 2008, c 212, § §4, 7; am L 2009, c 11, §20 and c 96, §3; am L 2013, c 184, §2; am L 2014, c 9, §10]\n\nThe repeal and reenactment note at this section in the main volume took effect on January 1, 2016, pursuant to L 2013, c 184, §2; L 2014, c 9, §10.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-14/"
    },
    {
      "id": "section-461-15",
      "number": "461-15",
      "heading": "Miscellaneous permits.",
      "text": "§461-15 Miscellaneous permits.(a) It shall be unlawful:\n\n(1) For any person to sell or offer for sale at public auction, or to sell or offer for sale at private sale in a place where public auctions are conducted, any prescription drugs without first obtaining a permit from the board of pharmacy to do so;\n\n(2) For any person to distribute or dispense samples of any prescription drugs without first obtaining a permit from the board to do so; provided that nothing in this paragraph shall interfere with the furnishing of samples or drugs directly to physicians, druggists, dentists, veterinarians, and optometrists for use in their professional practice;\n\n(3) For wholesalers to sell, distribute, or dispense any prescription drug, except to a pharmacist, physician, dentist, veterinarian, or optometrist who is allowed to use pharmaceutical agents under chapter 459 or to a generally recognized industrial, agricultural, manufacturing, or scientific user of drugs for professional or business purposes; provided that it shall be unlawful for wholesalers to sell, distribute, or dispense any prescription pharmaceutical agent that is not approved by the Hawaii board of optometry;\n\n(4) For any wholesale prescription drug distributor to sell or distribute medical oxygen except to a:\n\n(A) Licensed practitioner with prescriptive authority;\n\n(B) Pharmacist;\n\n(C) Medical oxygen distributor;\n\n(D) Patient or a patient's agent pursuant to a prescription; or\n\n(E) Emergency medical services for administration by trained personnel for oxygen deficiency and resuscitation;\n\n(5) For any medical oxygen distributor to supply medical oxygen pursuant to a prescription order, to a patient or a patient's agent, without first obtaining a permit from the board to do so;\n\n(6) For any person, as principal or agent, to conduct or engage in the business of preparing, manufacturing, compounding, packing, or repacking any drug without first obtaining a permit from the board to do so; and\n\n(7) For any out-of-state pharmacy or entity engaging in the practice of pharmacy, in any manner to distribute, ship, mail, or deliver prescription drugs or devices into the State without first obtaining a permit from the board; provided that the applicant shall:\n\n(A) Provide the location, names, and titles of all principal corporate officers;\n\n(B) Attest that the applicant or any personnel of the applicant has not been found in violation of any state or federal drug laws, including the illegal use of drugs or improper distribution of drugs;\n\n(C) Submit verification of a valid unexpired license, permit, or registration in good standing to conduct the pharmacy in compliance with the laws of the home state and agree to maintain in good standing the license, permit, or registration; and\n\n(D) Have in its employ a registered pharmacist whose registration is current and in good standing.\n\n(b) A person whose application for a permit has been denied may file for an administrative hearing in conformity with chapter 91. [L 1949, c 175, pt of §1; am L 1953, c 76, §2; RL 1955, §71-15; HRS §461-15; am L 1985, c 294, §5; am L 1993, c 259, §1; am L 2000, c 83, §7; am L 2002, c 164, §5; am L 2018, c 203, §6]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-15/"
    },
    {
      "id": "section-461-155",
      "number": "461-15.5",
      "heading": "Distribution of dialysate drugs and devices.",
      "text": "§461-15.5 Distribution of dialysate drugs and devices.(a) The license, registration, and permit requirements of this chapter shall not apply to a manufacturer, wholesale distributor, manufacturer engaged in direct distribution to qualified persons, or third-party logistics provider, to the extent the manufacturer, wholesale distributor, manufacturer engaged in direct distribution to qualified persons, or third-party logistics provider is engaged in the distribution of dialysate drugs or devices necessary to perform home dialysis on patients with end-stage renal disease; provided that the following criteria shall be met:\n\n(1) The dialysate drugs or devices are approved by the United States Food and Drug Administration, as required by federal law;\n\n(2) The dialysate drugs or devices are lawfully held by a manufacturer or a manufacturer's agent that is properly licensed with the board as a manufacturer, wholesale distributor, or manufacturer engaged in direct distribution to qualified persons;\n\n(3) The dialysate drugs or devices are held and delivered in the original, sealed, and labeled packaging from the manufacturing facility;\n\n(4) The dialysate drugs or devices are delivered only by the manufacturer or the manufacturer's agent and only upon receipt of an order by a physician, a physician assistant, or an advanced practice registered nurse with prescriptive authority; and\n\n(5) The manufacturer or the manufacturer's agent delivers the dialysate drugs or devices directly to:\n\n(A) A patient with end-stage renal disease, or the patient's designee, for the patient's self-administration of dialysis therapy; or\n\n(B) A health care provider or an institution for administration or delivery of dialysis therapy to a patient with end-stage renal disease.\n\n(b) For the purposes of this section:\n\n\"Manufacturer\" has the same meaning as in section 328-112.\n\n\"Third-party logistics provider\" means an entity that provides or coordinates warehousing or other logistics services on behalf of a manufacturer, wholesale distributor, or dispenser of a product.\n\n\"Wholesale distributor\" has the same meaning as in section 328-112. [L 2023, c 101, §1]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-15-5/"
    },
    {
      "id": "section-461-16",
      "number": "461-16",
      "heading": "Fees for permits and licenses; renewal.",
      "text": "§461-16 Fees for permits and licenses; renewal.(a) The board shall collect application, license, and permit fees for each permit to operate a pharmacy or for each license to operate as a wholesale prescription drug distributor and a fee for the issuance of a permit in accordance with section 461-15(a)(1), (5), (6) and (7).\n\n(b) Permits issued under sections 461-14 and 461-15 and licenses issued under section 461-8.6 shall be conspicuously displayed in the place for which the permit or license was granted. The permits and licenses shall not be transferable, shall expire on December 31 of each odd-numbered year following the date of issuance, and shall be renewed biennially.\n\n(c) The holder of an expired permit or an expired license to operate as a wholesale prescription drug distributor may have the same restored within three years of the date of expiration upon due application therefor and payment of the delinquent fees and a penalty fee; provided that in the case of an expired permit, the holder of the expired permit meets the requirements for the renewal of permits. [L 1949, c 175, pt of §1; am L 1953, c 76, §3; RL 1955, §71-16; am L 1961, c 142, §8(c), (d); HRS §461-16; am L 1975, c 118, §25(2); am L 1984, c 7, §66; am L 1986, c 143, §14; am L 1992, c 196, §6; am L 1993, c 259, §2; am L 2000, c 83, §8]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-16/"
    },
    {
      "id": "section-461-165",
      "number": "461-16.5",
      "heading": "REPEALED.",
      "text": "§461-16.5 REPEALED.\n\nL 1992, c 202, §226.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-16-5/"
    },
    {
      "id": "section-461-17",
      "number": "461-17",
      "heading": "Penalties.",
      "text": "§461-17 Penalties.Any person violating this chapter or the rules duly prescribed by the board of pharmacy shall be fined not more than $500, or imprisoned not more than six months, or both. [L 1949, c 175, pt of §1; RL 1955, §71-17; HRS §461-17; am L 1983, c 23, §6]\n\nCross References\n\nClassification of offense and authorized punishment, see § §701-107, 706-640, and 706-663.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-17/"
    },
    {
      "id": "section-461-18",
      "number": "461-18",
      "heading": "Right of injunction.",
      "text": "§461-18 Right of injunction.The department may, in addition to any other remedies available, apply to a court having competent jurisdiction for an injunction to restrain any violation of this chapter. [L 1949, c 175, pt of §1; RL 1955, §71-18; HRS §461-18; am L 1986, c 143, §16]\n\nRules of Court\n\nInjunctions, see HRCP rule 65.",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-18/"
    },
    {
      "id": "section-461-19",
      "number": "461-19",
      "heading": "Application of law.",
      "text": "§461-19 Application of law.This chapter shall not apply to any practitioner legally licensed by the State or authorized by the laws of the State to prescribe prescription drugs within the scope of the practitioner's practice when the practitioner is handling drugs in the course of the practitioner's professional duties or prohibit the practitioner from personally supplying the practitioner's own patients with such prescription drugs if the prescription drugs fall within the practitioner's scope of authorized practice. [L 1949, c 175, pt of §1; RL 1955, §71-19; am L 1964, c 15, §5; HRS §461-19; gen ch 1985; am L 1995, c 34, §6; am L 1997, c 214, §9]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-19/"
    },
    {
      "id": "section-461-20",
      "number": "461-20",
      "heading": "Poison law not amended.",
      "text": "§461-20 Poison law not amended.Nothing in this chapter amends chapter 330. [L 1949, c 175, §2; RL 1955, §71-20; HRS §461-20]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-20/"
    },
    {
      "id": "section-461-21",
      "number": "461-21",
      "heading": "Disciplinary action.",
      "text": "§461-21 Disciplinary action.(a) In addition to any other actions authorized by law, the board may deny, revoke, or suspend any license or permit applied for or issued by the board, in accordance with this chapter, and fine or otherwise discipline a licensee or permit holder for any cause authorized by law, including but not limited to the following:\n\n(1) Procuring a license through fraud, misrepresentation, or deceit;\n\n(2) Professional misconduct, gross carelessness, or manifest incapacity;\n\n(3) Permitting an unlicensed person to perform activities that require a license under this chapter;\n\n(4) Violation of any of the provisions of this chapter or the rules adopted pursuant thereto;\n\n(5) Violation of any state or federal drug, controlled substance, or poison law;\n\n(6) False, fraudulent, or deceptive advertising;\n\n(7) Any other conduct constituting fraudulent or dishonest dealings;\n\n(8) Failure to comply with a board order;\n\n(9) Making a false statement on any document submitted or required to be filed by this chapter, including a false certification of compliance with the continuing education requirement;\n\n(10) Habitual intemperance or addiction to the use of habit-forming drugs;\n\n(11) Administering a vaccine, including a human papillomavirus, Tdap (tetanus, diphtheria, pertussis), meningococcal, or influenza vaccine, without complying with section 461-11.4; or\n\n(12) Prescribing or dispensing contraceptive supplies without complying with section 461-11.6.\n\n(b) Any person who violates any of the provisions of this chapter or the rules adopted pursuant thereto shall be fined not less than $100 nor more than $1,000 for each violation.\n\n(c) All proceedings for denial, suspension, fine, or revocation of a license or permit on any grounds specified in subsection (a) shall be conducted pursuant to chapter 91, including the right of judicial review. [L 1986, c 143, §2; am L 1992, c 202, §139; am L 2004, c 165, §4; am L 2012, c 42, §5; am L 2015, c 36, §4; am L 2017, c 67, §7 and c 68, §5]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-21/"
    },
    {
      "id": "section-461-215",
      "number": "461-21.5",
      "heading": "Discipline based on action taken by another state or federal agency; conditions; prohibition on practice.",
      "text": "§461-21.5 Discipline based on action taken by another state or federal agency; conditions; prohibition on practice.(a) Upon receipt of evidence of revocation, suspension, or other disciplinary action against a licensee by another state or federal agency, the board may issue an order imposing disciplinary action upon the licensee on the following conditions:\n\n(1) The board shall serve the licensee with a proposed order imposing disciplinary action as required by chapter 91;\n\n(2) The licensee shall have the right to request a hearing pursuant to chapter 91 to show cause why the action described in the proposed order should not be imposed;\n\n(3) Any request for a hearing shall be made in writing and filed with the board within twenty days after mailing of the proposed order to the licensee; and\n\n(4) If the licensee does not submit a written request for a hearing within twenty days after mailing of the proposed order, the board shall issue a final order imposing the disciplinary action described in the proposed order;\n\nprovided that the board shall not issue an order imposing disciplinary action upon the licensee if the revocation, suspension, or other disciplinary action against a licensee by another state was based on the provision or assistance in receipt or provision of medical, surgical, pharmaceutical, counseling, or referral services relating to the human reproductive system, including but not limited to services relating to pregnancy, contraception, or the termination of a pregnancy, so long as the provision or assistance in receipt or provision of the services was in accordance with the laws of this State or would have been in accordance with the laws of this State if it occurred within this State.\n\n(b) A certified copy of the disciplinary action by another state or federal agency shall constitute prima facie evidence of the disciplinary action.\n\n(c) A licensee against whom the board has issued a proposed order under this section shall be prohibited from practicing in this State until the board issues a final order if:\n\n(1) The licensee was the subject of disciplinary action by another state, except where the disciplinary action against the licensee by another state was based on the provision or assistance in receipt or provision of medical, surgical, pharmaceutical, counseling, or referral services relating to the human reproductive system, including but not limited to services relating to pregnancy, contraception, or the termination of a pregnancy, so long as the provision or assistance in receipt or provision of the services was in accordance with the laws of this State or would have been in accordance with the laws of this State if it occurred within this State; and\n\n(2) The disciplinary action by another state prohibits the licensee from practicing in that state.\n\n(d) In addition to the provisions of this section, the board may take any other action authorized by this chapter or chapter 436B.\n\n(e) Notwithstanding any law to the contrary, the final order of discipline taken pursuant to this section shall be a matter of public record. [L 2016, c 38, §5; am L 2023, c 2, §12]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-21-5/"
    },
    {
      "id": "section-461-22",
      "number": "461-22",
      "heading": "Cumulative remedies.",
      "text": "§461-22 Cumulative remedies.The remedies or penalties provided by this chapter are cumulative to each other and to the remedies or penalties available under all other laws of this State. [L 1986, c 143, §3]",
      "history": "",
      "source_url": "https://law.justia.com/codes/hawaii/title-25/chapter-461/section-461-22/"
    }
  ]
}